Unitree Robotics has set a timetable for its Shanghai initial public offering. According to the filing, subscriptions will open on August 10 at a valuation of about 42 billion yuan, or $5.7 billion, for the Hangzhou-based robotics maker.

The company would become the first major producer of humanoid robots to list on the Chinese mainland, giving investors a public benchmark for an embodied AI sector that until now has relied on venture capital funding and demo-day presentations.

Unitree prices the deal and turns a rare profit

Preliminary price consultations begin Wednesday, while online and institutional subscriptions open on August 10. Payment is due on August 12.

Unitree is seeking to raise 4.202 billion yuan, or $618 million, by issuing 40.45 million new shares, equal to 10% of its enlarged share capital, on the STAR Market of the Shanghai Stock Exchange. The fundraising target implies a valuation of roughly 42 billion yuan, although the final figure will be determined through book building.

The path to the offering was cleared in early July, when the China Securities Regulatory Commission approved Unitree’s registration, Cryptopolitan reported at the time.

Most competitors remain unprofitable, but Unitree is not. As previously covered by Cryptopolitan, the company reported 1.7 billion yuan, or $250 million, in revenue for 2025 and 591 million yuan, or $87 million, in adjusted profit.

Revenue rose from 159 million yuan in 2023 to 393 million yuan in 2024, then increased about fourfold last year, while net profit jumped 674% year over year. Humanoid robots drove sales, accounting for more than half of revenue in the first nine months of 2025.

By comparison, UBTech Robotics, a rival listed in Hong Kong, generated 2 billion yuan in revenue over the same period but posted a net loss of about 700 million yuan.

Unitree’s manufacturing plans draw Nvidia and Washington attention

Unitree said it will use the proceeds to develop robot “brains,” conduct research on robot bodies, launch new products, and build a manufacturing base capable of producing 75,000 humanoid robots and 115,000 quadruped robots annually. The planned factory scale underscores why the listing matters beyond one company: it offers a test case for how quickly China’s robotics supply chain can support mass production rather than only prototypes.

About 90% of Unitree’s supply chain is in China, a setup that lowers costs and speeds iteration. The company believes the stock could eventually be worth as much as 109 billion yuan on the secondary market.

Nvidia has selected Unitree’s G1 humanoid as the basis for its Isaac GR00T research platform, which pairs the robot with Nvidia’s Jetson Thor computer and is being tested at Stanford, UC San Diego, and ETH Zurich.

Cryptopolitan reported that Japan Airlines began a three-year trial in May 2026 using two Unitree robots at Tokyo’s Haneda Airport to handle baggage and cabin work.

US lawmakers have questioned Unitree over alleged ties to the Chinese government and have proposed restrictions on its use in federally funded research, highlighting how the company’s growth sits at the intersection of commercial robotics, research partnerships, and national-security scrutiny.

Wang Peng, a senior researcher at the Beijing Academy of Social Sciences, called the IPO “a milestone for China’s embodied AI industry” and said it could change how the sector is valued. China already dominates the manufacturing side of the industry, accounting for 84.7% of the roughly 17,000 humanoid robots shipped worldwide in 2025.